Letters

Response—Evaluating human trials: FDA's role

See allHide authors and affiliations

Science  22 Jun 2018:
Vol. 360, Issue 6395, pp. 1308-1309
DOI: 10.1126/science.aau0865

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article